Federation des caisses Desjardins du Quebec’s Galera Therapeutics, Inc. Common Stock GRTX Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio GRTX Stock Details GRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-50,000	Closed	-$8.75K	–	2474
2023 Q3	$8.75K	Buy	+50,000	New	+$62.1K	﹤0.01%	1802
2023 Q2	–	Sell	-2,100	Closed	-$5.38K	–	2393
2023 Q1	$5.38K	Hold	2,100	–	–	﹤0.01%	1890
2022 Q4	$3.13K	Hold	2,100	–	–	﹤0.01%	2133
2022 Q3	$3.65K	Hold	2,100	–	–	﹤0.01%	2150
2022 Q2	$2.73K	Hold	2,100	–	–	﹤0.01%	2258
2022 Q1	$5K	Hold	2,100	–	–	﹤0.01%	2193
2021 Q4	$9.64K	Buy	+2,100	New	+$6.94K	﹤0.01%	2028

Other funds holding GRTX

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

NFGH

Nan Fung Group Holdings Kai Tak, Hong Kong $121M AUM 56.89% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's GRTX Position: Q4 2023 in Review

Federation des caisses Desjardins du Quebec sold out of Galera Therapeutics, Inc. Common Stock (GRTX) in Q4 2023, closing a stake of 50,000 shares — an estimated $8.75K sold.

Federation des caisses Desjardins du Quebec first reported a position in GRTX in Q4 2021 and held it in 7 quarters. The position peaked at $9.64K in Q4 2021. 37 funds tracked by Wall St. Rank hold GRTX as of Q4 2023.

Federation des caisses Desjardins du Quebec reported no remaining Galera Therapeutics, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Federation des caisses Desjardins du Quebec sold 50,000 Galera Therapeutics, Inc. Common Stock shares in Q4 2023, an estimated $8.75K.
Federation des caisses Desjardins du Quebec first reported a position in Galera Therapeutics, Inc. Common Stock in Q4 2021 and held it in 7 quarters.
Federation des caisses Desjardins du Quebec's Galera Therapeutics, Inc. Common Stock position peaked at $9.64K in Q4 2021.
37 funds tracked by Wall St. Rank held Galera Therapeutics, Inc. Common Stock as of Q4 2023.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q4 2023, filed 15 Aug 2024.